Dr. Smith Evening Primrose Oil Caps 500 mg/Naktssveces eļļa kapsula לטביה - לטבית - Pārtikas un veterinārais dienests, Zemkopības ministrija

dr. smith evening primrose oil caps 500 mg/naktssveces eļļa kapsula

cipla ltd. - kapsula

Dr. Smith’ s Garlic Oil Capsules 0.25%/Ķiploku eļļa kapsula לטביה - לטבית - Pārtikas un veterinārais dienests, Zemkopības ministrija

dr. smith’ s garlic oil capsules 0.25%/Ķiploku eļļa kapsula

cipla ltd. - kapsula

Unifarma Herbals Chyawanprash Bagātināts ar embliku AMLA (Paziņots 2008.) cits, džems לטביה - לטבית - Pārtikas un veterinārais dienests, Zemkopības ministrija

unifarma herbals chyawanprash bagātināts ar embliku amla (paziņots 2008.) cits, džems

cipla ltd. ,mumbai central, mumbai 400 008 vai shree baidyanath ayurved bhwan pvt. ltd., 1 gupta lane, kolkata -700 006 - cits, džems

Citrosol (Paziņots 2008.) šķidrums לטביה - לטבית - Pārtikas un veterinārais dienests, Zemkopības ministrija

citrosol (paziņots 2008.) šķidrums

cipla ltd. - šķidrums

Zivju eļļa - 1000 (Paziņots) cits, mīkstā želatīna kapsula לטביה - לטבית - Pārtikas un veterinārais dienests, Zemkopības ministrija

zivju eļļa - 1000 (paziņots) cits, mīkstā želatīna kapsula

cipla ltd. - cits, mīkstā želatīna kapsula

Cisplatin Teva 0,5 mg/ml koncentrāts infūziju šķīduma pagatavošanai לטביה - לטבית - Zāļu valsts aģentūra

cisplatin teva 0,5 mg/ml koncentrāts infūziju šķīduma pagatavošanai

teva pharma b.v., netherlands - cisplatīns - koncentrāts infūziju šķīduma pagatavošanai - 0,5 mg/ml

Unisol 0,5 mg/0,4 mg cietās kapsulas לטביה - לטבית - Zāļu valsts aģentūra

unisol 0,5 mg/0,4 mg cietās kapsulas

exeltis baltics uab, lithuania - dutasteridum, tamsulosini hydrochloridum - kapsula, cietā - 0,5 mg/0,4 mg

Alymsys האיחוד האירופי - לטבית - EMA (European Medicines Agency)

alymsys

mabxience research sl - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiski līdzekļi - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Oxaliplatin Hospira 5 mg/ml koncentrāts infūziju šķīduma pagatavošanai לטביה - לטבית - Zāļu valsts aģentūra

oxaliplatin hospira 5 mg/ml koncentrāts infūziju šķīduma pagatavošanai

hospira uk limited, united kingdom - oksaliplatīns - koncentrāts infūziju šķīduma pagatavošanai - 5 mg/ml

Docetaxel Hospira 10 mg/ml koncentrāts infūziju šķīduma pagatavošanai לטביה - לטבית - Zāļu valsts aģentūra

docetaxel hospira 10 mg/ml koncentrāts infūziju šķīduma pagatavošanai

hospira uk limited, united kingdom - docetaksels - koncentrāts infūziju šķīduma pagatavošanai - 10 mg/ml